Halozyme Therapeutics Inc. (HALO) Stock is Just Right Size-Neither Too Big Nor Too Small
TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]
The market value of Halozyme Therapeutics Inc. (HALO) Stock is expected to soar in the coming months
TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]
Halozyme Therapeutics Inc. (HALO) Stock Is Emerging from the Clouds
TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]
Earnings and valuation of Halozyme Therapeutics Inc. (HALO) Stock are impressive
TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]
What does the future hold for Halozyme Therapeutics Inc. (HALO) Stock?
TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]
Halozyme Therapeutics Inc. (NASDAQ:HALO) Stock is trading Higher 5.64% From 200-Day SMA
TD Cowen raised the price target for the Halozyme Therapeutics Inc. (NASDAQ:HALO) stock to “an Outperform”. The rating was released on February 29, 2024, according to finviz. The research report from Goldman has downgraded the stock from Buy to Neutral, with a price target set at $45. The stock was upgraded by Piper Sandler, who […]